Frankfurt - Delayed Quote EUR

FitLife Brands, Inc. (QO8.F)

Compare
30.50 +0.90 (+3.04%)
At close: December 27 at 3:46:35 PM GMT+1
Loading Chart for QO8.F
DELL
  • Previous Close 29.60
  • Open 30.30
  • Bid 30.70 x --
  • Ask 31.60 x --
  • Day's Range 30.30 - 30.50
  • 52 Week Range 19.36 - 32.50
  • Volume 43
  • Avg. Volume 8
  • Market Cap (intraday) 142.123M
  • Beta (5Y Monthly) 1.01
  • PE Ratio (TTM) 18.71
  • EPS (TTM) 1.63
  • Earnings Date Nov 14, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

FitLife Brands, Inc. provides nutritional supplements for health-conscious consumers in the United States and internationally. The company provides weight loss, sports nutrition, and general health products; sports nutrition products; weight loss and sports nutrition products; sports nutrition and general wellness formulations with an emphasis on natural, vegan, and organic ingredients; and male health and weight loss products, as well as other diet, health, and sports nutrition supplements and related products; and value-oriented sports nutrition and weight loss products. It offers MRC products which includes general health supplements; and natural skincare and beauty products. In addition, it markets its products under the brand names of NDS Nutrition, PMD Sports, SirenLabs, CoreActive, Nutrology, Metis Nutrition, iSatori, BioGenetic Laboratories, Energize, Dr. Tobias, All-Natural Advice, and Maritime Naturals through franchised stores, as well as through retail locations, which include specialty, mass, and online. The company was formerly known as Bond Laboratories, Inc. and changed its name to FitLife Brands, Inc. in September 2013. FitLife Brands, Inc. was incorporated in 2005 and is headquartered in Omaha, Nebraska.

www.fitlifebrands.com

37

Full Time Employees

December 31

Fiscal Year Ends

Recent News: QO8.F

View More

Performance Overview: QO8.F

Trailing total returns as of 12/27/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

QO8.F
56.47%
S&P 500
25.18%

1-Year Return

QO8.F
56.47%
S&P 500
25.05%

3-Year Return

QO8.F
56.47%
S&P 500
26.35%

5-Year Return

QO8.F
56.47%
S&P 500
84.29%

Compare To: QO8.F

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: QO8.F

View More

Valuation Measures

As of 12/27/2024
  • Market Cap

    141.80M

  • Enterprise Value

    151.34M

  • Trailing P/E

    18.70

  • Forward P/E

    14.45

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.50

  • Price/Book (mrq)

    4.28

  • Enterprise Value/Revenue

    2.51

  • Enterprise Value/EBITDA

    12.57

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    13.12%

  • Return on Assets (ttm)

    14.14%

  • Return on Equity (ttm)

    28.59%

  • Revenue (ttm)

    60.68M

  • Net Income Avi to Common (ttm)

    7.96M

  • Diluted EPS (ttm)

    1.63

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    3.68M

  • Total Debt/Equity (mrq)

    48.22%

  • Levered Free Cash Flow (ttm)

    -10.97M

Research Analysis: QO8.F

View More